vs
Bioventus Inc.（BVS）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Bioventus Inc.的季度营收约是Ranger Energy Services, Inc.的1.1倍（$157.9M vs $142.2M），Bioventus Inc.净利率更高（9.3% vs 2.3%，领先7.1%），Bioventus Inc.同比增速更快（2.8% vs -0.6%），Bioventus Inc.自由现金流更多（$37.4M vs $17.1M），过去两年Bioventus Inc.的营收复合增速更高（10.4% vs 1.9%）
Bioventus Inc.是一家全球化医疗技术企业，专注于骨科生物制剂领域，研发并商业化促进骨关节愈合、肌肉骨骼疼痛管理及再生护理的相关产品，服务全球多地的骨科临床医师、康复师及患者群体。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
BVS vs RNGR — 直观对比
营收规模更大
BVS
是对方的1.1倍
$142.2M
营收增速更快
BVS
高出3.4%
-0.6%
净利率更高
BVS
高出7.1%
2.3%
自由现金流更多
BVS
多$20.3M
$17.1M
两年增速更快
BVS
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $157.9M | $142.2M |
| 净利润 | $14.8M | $3.2M |
| 毛利率 | 68.9% | — |
| 营业利润率 | 12.3% | 2.3% |
| 净利率 | 9.3% | 2.3% |
| 营收同比 | 2.8% | -0.6% |
| 净利润同比 | 3902.8% | -44.8% |
| 每股收益（稀释后） | $0.21 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BVSRNGR
| Q4 25 | $157.9M | $142.2M | ||
| Q3 25 | $138.7M | $128.9M | ||
| Q2 25 | $147.7M | $140.6M | ||
| Q1 25 | $123.9M | $135.2M | ||
| Q4 24 | $153.6M | $143.1M | ||
| Q3 24 | $139.0M | $153.0M | ||
| Q2 24 | $151.2M | $138.1M | ||
| Q1 24 | $129.5M | $136.9M |
净利润BVSRNGR
| Q4 25 | $14.8M | $3.2M | ||
| Q3 25 | $3.2M | $1.2M | ||
| Q2 25 | $7.5M | $7.3M | ||
| Q1 25 | $-2.6M | $600.0K | ||
| Q4 24 | $-388.0K | $5.8M | ||
| Q3 24 | $-5.2M | $8.7M | ||
| Q2 24 | $-25.7M | $4.7M | ||
| Q1 24 | $-4.9M | $-800.0K |
毛利率BVSRNGR
| Q4 25 | 68.9% | — | ||
| Q3 25 | 68.0% | — | ||
| Q2 25 | 69.1% | — | ||
| Q1 25 | 67.0% | — | ||
| Q4 24 | 66.8% | — | ||
| Q3 24 | 67.3% | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | 68.3% | — |
营业利润率BVSRNGR
| Q4 25 | 12.3% | 2.3% | ||
| Q3 25 | 8.1% | 2.0% | ||
| Q2 25 | 12.4% | 6.1% | ||
| Q1 25 | 3.9% | 0.7% | ||
| Q4 24 | 5.0% | 6.2% | ||
| Q3 24 | 2.6% | 8.4% | ||
| Q2 24 | -20.8% | 5.3% | ||
| Q1 24 | 3.8% | -0.4% |
净利率BVSRNGR
| Q4 25 | 9.3% | 2.3% | ||
| Q3 25 | 2.3% | 0.9% | ||
| Q2 25 | 5.1% | 5.2% | ||
| Q1 25 | -2.1% | 0.4% | ||
| Q4 24 | -0.3% | 4.1% | ||
| Q3 24 | -3.7% | 5.7% | ||
| Q2 24 | -17.0% | 3.4% | ||
| Q1 24 | -3.8% | -0.6% |
每股收益（稀释后）BVSRNGR
| Q4 25 | $0.21 | $0.14 | ||
| Q3 25 | $0.05 | $0.05 | ||
| Q2 25 | $0.11 | $0.32 | ||
| Q1 25 | $-0.04 | $0.03 | ||
| Q4 24 | $0.00 | $0.24 | ||
| Q3 24 | $-0.08 | $0.39 | ||
| Q2 24 | $-0.40 | $0.21 | ||
| Q1 24 | $-0.08 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.2M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $184.1M | $300.1M |
| 总资产 | $683.6M | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BVSRNGR
| Q4 25 | $51.2M | $10.3M | ||
| Q3 25 | $42.2M | $45.2M | ||
| Q2 25 | $32.9M | $48.9M | ||
| Q1 25 | $22.8M | $40.3M | ||
| Q4 24 | $41.6M | $40.9M | ||
| Q3 24 | $43.1M | $14.8M | ||
| Q2 24 | $32.0M | $8.7M | ||
| Q1 24 | $25.2M | $11.1M |
总债务BVSRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益BVSRNGR
| Q4 25 | $184.1M | $300.1M | ||
| Q3 25 | $166.1M | $270.0M | ||
| Q2 25 | $161.2M | $276.9M | ||
| Q1 25 | $148.1M | $272.6M | ||
| Q4 24 | $147.9M | $273.8M | ||
| Q3 24 | $148.7M | $267.6M | ||
| Q2 24 | $150.9M | $260.5M | ||
| Q1 24 | $171.3M | $261.7M |
总资产BVSRNGR
| Q4 25 | $683.6M | $419.3M | ||
| Q3 25 | $701.6M | $372.8M | ||
| Q2 25 | $706.8M | $381.7M | ||
| Q1 25 | $691.4M | $376.5M | ||
| Q4 24 | $728.0M | $381.6M | ||
| Q3 24 | $769.5M | $373.9M | ||
| Q2 24 | $792.2M | $359.6M | ||
| Q1 24 | $794.2M | $355.5M |
负债/权益比BVSRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.0M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $37.4M | $17.1M |
| 自由现金流率自由现金流/营收 | 23.7% | 12.0% |
| 资本支出强度资本支出/营收 | 0.4% | 4.9% |
| 现金转化率经营现金流/净利润 | 2.57× | 7.53× |
| 过去12个月自由现金流最近4个季度 | $72.1M | $42.9M |
8季度趋势，按日历期对齐
经营现金流BVSRNGR
| Q4 25 | $38.0M | $24.1M | ||
| Q3 25 | $30.1M | $13.6M | ||
| Q2 25 | $25.9M | $20.7M | ||
| Q1 25 | $-19.3M | $10.6M | ||
| Q4 24 | $19.3M | $32.7M | ||
| Q3 24 | $10.3M | $17.7M | ||
| Q2 24 | $15.2M | $22.1M | ||
| Q1 24 | $-6.0M | $12.0M |
自由现金流BVSRNGR
| Q4 25 | $37.4M | $17.1M | ||
| Q3 25 | $29.6M | $8.0M | ||
| Q2 25 | $25.3M | $14.4M | ||
| Q1 25 | $-20.2M | $3.4M | ||
| Q4 24 | $18.7M | $27.3M | ||
| Q3 24 | $10.3M | $10.8M | ||
| Q2 24 | $15.1M | $6.8M | ||
| Q1 24 | $-6.3M | $5.5M |
自由现金流率BVSRNGR
| Q4 25 | 23.7% | 12.0% | ||
| Q3 25 | 21.4% | 6.2% | ||
| Q2 25 | 17.1% | 10.2% | ||
| Q1 25 | -16.3% | 2.5% | ||
| Q4 24 | 12.2% | 19.1% | ||
| Q3 24 | 7.4% | 7.1% | ||
| Q2 24 | 10.0% | 4.9% | ||
| Q1 24 | -4.9% | 4.0% |
资本支出强度BVSRNGR
| Q4 25 | 0.4% | 4.9% | ||
| Q3 25 | 0.3% | 4.3% | ||
| Q2 25 | 0.5% | 4.5% | ||
| Q1 25 | 0.7% | 5.3% | ||
| Q4 24 | 0.4% | 3.8% | ||
| Q3 24 | 0.0% | 4.5% | ||
| Q2 24 | 0.1% | 11.1% | ||
| Q1 24 | 0.2% | 4.7% |
现金转化率BVSRNGR
| Q4 25 | 2.57× | 7.53× | ||
| Q3 25 | 9.54× | 11.33× | ||
| Q2 25 | 3.48× | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BVS
| Pain Treatments | $71.1M | 45% |
| Surgical Solutions | $48.9M | 31% |
| Restorative Therapies | $19.5M | 12% |
| Other | $18.4M | 12% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
